PAL 217
Study / Research
A marker recently approved by the FDA for early detection of Alzheimer's, which was lowered by 28% in Brian Johnson due to HBOT, and is considered for re-testing after sauna therapy.
Mentioned in 1 video
A marker recently approved by the FDA for early detection of Alzheimer's, which was lowered by 28% in Brian Johnson due to HBOT, and is considered for re-testing after sauna therapy.
